elecell lnc. (CEO Hyung-seop Han), a company specializing in biomimetic electrical stimulation-based therapeutic devices, has been finally selected for the '2026 Innovative Bio-Technology Awards,' organized by the JoongAng Ilbo and sponsored by the Korea Institute of Science and Technology (KIST), the Korea Biotechnology Association, and the Korea Institute of Industrial Technology Planning and Evaluation (KEIT).

The '2026 Innovation Bio Technology Awards' is an awards system established to discover companies that have achieved unique technological results across the bio industry and demonstrated market competitiveness and potential. elecell was named to the list of winners in recognition of its original source technology in the field of next-generation bio-therapeutic platforms.

An official from elecell (CEO Hyung-seop Han) stated, “Winning the Innovation Bio Technology Award is an opportunity to once again recognize the originality and value of the biocurrent-based regenerative medicine technology that Electel has developed,” adding, “With the recently completed US FDA registration and the push to establish a local headquarters in Texas TMC, we will secure global clinical data and actively expand our market share.”

Link to original article: https://www.joongang.co.kr/article/25439573